Common use of Medication Support Services Clause in Contracts

Medication Support Services. Evaluate need for medication, clinical effectiveness, side 24 effects of medication, and obtaining informed consent. 25 a. Medication education shall be provided including discussing risks, benefits and 26 alternatives with the clients or significant support persons. 27 b. Plan development related to decreasing impairments, delivery of services, and 28 evaluation of the status of the client's community functions; and prescribing, dispensing, and 29 administering psychotropic medications shall be discussed with the client and documented.

Medication Support Services. Evaluate need for medication, clinical effectiveness, side 24 29 effects of medication, medication and obtaining informed consent. 25 30 a. Medication education shall be provided including discussing risks, benefits and 26 31 alternatives with the clients or significant support persons. 27 32 b. Plan development related to decreasing impairments, delivery of services, and 28 evaluation of 33 the status of the client's community functions; and , prescribing, dispensing, dispensing and 29 administering psychotropic 34 medications shall be discussed with the client and documented.

Medication Support Services. Evaluate need for medication, clinical effectiveness, side 24 14 effects of medication, medication and obtaining informed consent.. 15 // 25 16 a. Medication education shall be provided including discussing risks, benefits and 26 17 alternatives with the clients Consumers or significant support persons. 27 18 b. Plan development related to decreasing impairments, delivery of services, and 28 evaluation of 19 the status of the clientConsumer's community functions; and , prescribing, dispensing, dispensing and 29 administering 20 psychotropic medications shall be discussed with the client Consumer and documented.

Medication Support Services. Evaluate need for medication, clinical effectiveness, side 24 37 effects of medication, medication and obtaining informed consent. 25 1 a. Medication education shall be provided including discussing risks, benefits and 26 2 alternatives with the clients Clients or significant support persons. 27 3 b. Plan development related to decreasing impairments, delivery delivering of services, and 28 evaluation of evaluating 4 the status of the clientClient's community functions; , and prescribing, dispensing, and 29 administering 5 psychotropic medications shall be discussed with the client Client and documented.

Medication Support Services. Evaluate need for medication, clinical effectiveness, side 24 29 effects of medication, medication and obtaining informed consent.. 30 // 25 31 a. Medication education shall be provided including discussing risks, benefits and 26 32 alternatives with the clients clientsConsumers or significant support persons. 27 33 b. Plan development related to decreasing impairments, delivery of services, and 28 evaluation of 34 the status of the clientclient'sConsumer's community functions; and , prescribing, dispensing, dispensing and 29 administering 35 psychotropic medications shall be discussed with the client clientConsumer and documented.

Medication Support Services. Evaluate need for individual medication, clinical 14 effectiveness, side 24 effects of medication, medication and obtaining informed consent. 25 15 a. Medication education shall be provided including discussing risks, benefits and 26 16 alternatives with the clients or Clients and significant support personspersons when indicated. 27 17 b. Plan development related to decreasing impairments, delivery delivering of services, and 28 evaluation of evaluating 18 the status of the clientClient's community functions; , and prescribing, dispensing, dispensing and 29 administering psychotropic 19 medications shall be discussed with the client Client and documented. 20 c. Medication support services may occur in the office or in the field.

Medication Support Services. Evaluate need for medication, clinical effectiveness, side 24 27 effects of medication, medication and obtaining informed consent. 25 28 a. Medication education shall be provided including discussing risks, benefits and 26 29 alternatives with the clients Clients or significant support persons. 27 30 b. Plan development related to decreasing impairments, delivery delivering of services, and 28 evaluation of evaluating 31 the status of the clientClient's community functions; , and prescribing, dispensing, and 29 administering 32 psychotropic medications shall be discussed with the client Client and documented.

Medication Support Services. Evaluate need for individual medication, clinical 9 effectiveness, side 24 effects of medication, and obtaining informed consent. 25 10 a. Medication education shall be provided including discussing risks, benefits benefits, and 26 11 alternatives with the clients or Clients and significant support personspersons when indicated. 27 12 b. Plan development related to decreasing impairments, delivery delivering of services, and 28 evaluation of evaluating 13 the status of the clientClient's community functions; , and prescribing, dispensing, and 29 administering 14 psychotropic medications shall be discussed with the client Client and documented.

Medication Support Services. Evaluate need for medication, clinical effectiveness, side 24 19 effects of medication, and obtaining informed consent. 25 20 a. Medication education shall be provided including discussing risks, benefits and 26 21 alternatives with the clients or significant support persons. 27 22 b. Plan development related to decreasing impairments, delivery of services, and 28 23 evaluation of the status of the client's community functions; and prescribing, dispensing, and 29 24 administering psychotropic medications shall be discussed with the client and documented.

Medication Support Services. Evaluate need for medication, clinical effectiveness, side 24 13 effects of medication, and obtaining informed consent. 25 14 a. Medication education shall be provided including discussing risks, benefits and 26 15 alternatives with the clients or significant support persons. 27 16 b. Plan development related to decreasing impairments, delivery of services, and 28 17 evaluation of the status of the client's community functions; and prescribing, dispensing, and 29 18 administering psychotropic medications shall be discussed with the client and documented.